Enovis (ENOV) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Enovis insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $746K and 1 sold $45K of ENOV stock on the open market.
Get emailed when insiders cluster-buy stocks like ENOV
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ENOV insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $450K | 4 | — | 0 |
| Q2 2026 | $92K | 5 | — | 0 |
| Q1 2026 | $146K | 8 | — | 0 |
| Q4 2025 | $75K | 1 | $45K | 4 |
Valuation, profit and volume
Pick score 44/100Summary
Over the past 12 months, 3 Enovis CORP insiders reported open-market purchases totaling $746K, while 1 insider reported sales totaling $45K. Among insiders with enough purchase history to measure, Oliver Engert (Chief Administrative Officer) has the highest Insider Score at 11. 0 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ENOV stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Investor disclosure
- 8-K Earnings release
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 8SEC | Oliver EngertChief Administrative Officer | Buy | 2,66063,898 held (+4%) | $18.80 | $50K | -5.9% | 11 |
| Sep 4SEC | Damien McdonaldCEO | Buy | 13,035247,077 held (+6%) | $19.15 | $250K | -7.6% | — |
| Sep 4SEC | Oliver EngertChief Administrative Officer | Buy | 5,14061,238 held (+9%) | $19.46 | $100K | -9.1% | 11 |
| Sep 4SEC | Oliver EngertChief Administrative Officer | Buy | 2,45856,098 held (+5%) | $20.32 | $50K | -12.9% | 11 |
| Jun 16SEC | Oliver EngertChief Administrative Officer | Buy | 1,00053,640 held (+2%) | $20.92 | $21K | -15.4% | 11 |
| Jun 15SEC | Oliver EngertChief Administrative Officer | Buy | 1,00051,840 held (+2%) | $21.75 | $22K | -18.7% | 11 |
| Jun 15SEC | Oliver EngertChief Administrative Officer | Buy | 20050,840 held (+0%) | $20.99 | $4K | -15.7% | 11 |
| Jun 11SEC | Oliver EngertChief Administrative Officer | Buy | 1,00050,640 held (+2%) | $23.00 | $23K | -23.1% | 11 |
| Jun 3SEC | Oliver EngertChief Administrative Officer | Buy | 1,00049,640 held (+2%) | $22.22 | $22K | -20.4% | 11 |
| Mar 16SEC | Oliver EngertChief Administrative Officer | Buy | 1,00048,640 held (+2%) | $23.74 | $24K | -25.5% | 11 |
| Mar 12SEC | Oliver EngertChief Administrative Officer | Buy | 1,00047,640 held (+2%) | $23.93 | $24K | -26.1% | 11 |
| Mar 10SEC | Oliver EngertChief Administrative Officer | Buy | 1,00046,640 held (+2%) | $23.39 | $23K | -24.4% | 11 |
| Mar 10SEC | Oliver EngertChief Administrative Officer | Buy | 50045,640 held (+1%) | $24.48 | $12K | -27.7% | 11 |
| Mar 10SEC | Oliver EngertChief Administrative Officer | Buy | 25045,140 held (+1%) | $24.28 | $6K | -27.1% | 11 |
| Mar 5SEC | Oliver EngertChief Administrative Officer | Buy | 1,00044,640 held (+2%) | $24.77 | $25K | -28.6% | 11 |
| Mar 5SEC | Oliver EngertChief Administrative Officer | Buy | 25044,890 held (+1%) | $25.10 | $6K | -29.5% | 11 |
| Mar 3SEC | Oliver EngertChief Administrative Officer | Buy | 1,00043,640 held (+2%) | $25.50 | $26K | -30.6% | 11 |
| Dec 11SEC | Daniel A PryorFormer Evp, Strategy & Bus Dev | Sell | 666160,449 held (−0%) | $27.21 | $18K | -35.0% | — |
| Dec 11SEC | Daniel A PryorFormer Evp, Strategy & Bus Dev | Sell | 333 | $27.22 | $9K | -35.0% | — |
| Dec 11SEC | Daniel A PryorFormer Evp, Strategy & Bus Dev | Sell | 333 | $27.21 | $9K | -35.0% | — |
| Dec 11SEC | Daniel A PryorFormer Evp, Strategy & Bus Dev | Sell | 333 | $27.18 | $9K | -34.9% | — |
| Nov 28SEC | John KlecknerPrincipal Accounting Officer | Buy | 2,46812,302 held (+25%) | $30.32 | $75K | -41.7% | — |
Insiders at Enovis CORP
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Oliver EngertChief Administrative Officer | $438K | — | Sep 8, 2026 | 11 |
| Damien McdonaldCEO | $250K | — | Sep 4, 2026 | — |
| John KlecknerPrincipal Accounting Officer | $75K | — | Nov 28, 2025 | — |
| Daniel A PryorFormer Evp, Strategy & Bus Dev | — | $45K | Dec 11, 2025 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
ENOV stock: common questions
Are Enovis CORP insiders buying ENOV stock?
In the past 12 months, 3 insiders reported open-market purchases of ENOV worth $746K. The latest was Chief Administrative Officer Oliver Engert bought $50K of ENOV at $18.80.
Are Enovis CORP insiders selling ENOV stock?
1 insiders reported sales worth $45K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ENOV's 52-week range?
Over the past year ENOV has traded between $17.43 and $32.87. It last closed at $17.69 on Oct 9, 2026.